The shift from hospitals to Ambulatory Surgery Centers (ASCs) is driven by positive clinical outcomes, cost savings, and market growth. ASCs offer lower readmission rates, fewer post-surgical complications, and significant cost reductions—over $38 billion annually. COVID-19 accelerated this trend, but ASC procedure volumes continued rising post-pandemic, with a 47.1% increase from 2020 to 2021. Lower reimbursement rates for ASCs and improved efficiency attract more procedures, while acquisitions by companies like UnitedHealth highlight growth potential. Medical device companies must adapt strategies to target ASCs, leveraging data to identify opportunities in this expanding care setting.

Join for free to read